statistiche ricercatore

FORLANI, GRETA

Distribuzione geografica

Continente	#
NA - Nord America	6.573
EU - Europa	5.075
AS - Asia	1.225
SA - Sud America	7
Continente sconosciuto - Info sul continente non disponibili	6
AF - Africa	3
OC - Oceania	3
Totale	12.892

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.547
IT - Italia	2.719
UA - Ucraina	877
TR - Turchia	433
SE - Svezia	432
CN - Cina	311
VN - Vietnam	302
DE - Germania	277
IE - Irlanda	252
FI - Finlandia	237
SG - Singapore	130
GB - Regno Unito	124
FR - Francia	41
BE - Belgio	37
CA - Canada	25
JP - Giappone	25
CZ - Repubblica Ceca	17
RU - Federazione Russa	16
IN - India	13
BR - Brasile	6
CH - Svizzera	6
EU - Europa	6
NL - Olanda	6
AL - Albania	4
LU - Lussemburgo	4
PL - Polonia	4
AT - Austria	3
ES - Italia	3
HK - Hong Kong	3
KR - Corea	3
HR - Croazia	2
HU - Ungheria	2
NO - Norvegia	2
NZ - Nuova Zelanda	2
PK - Pakistan	2
RS - Serbia	2
AU - Australia	1
BA - Bosnia-Erzegovina	1
BT - Bhutan	1
DK - Danimarca	1
DZ - Algeria	1
EG - Egitto	1
GR - Grecia	1
LI - Liechtenstein	1
LT - Lituania	1
MD - Moldavia	1
ME - Montenegro	1
MK - Macedonia	1
MX - Messico	1
TW - Taiwan	1
UZ - Uzbekistan	1
VE - Venezuela	1
ZA - Sudafrica	1
Totale	12.892

Salva come PNG Salva come JPEG

Città	#
Milan	1.946
Fairfield	777
Jacksonville	690
Chandler	536
Woodbridge	533
Ashburn	434
Dearborn	406
Houston	396
Ann Arbor	345
Seattle	310
Wilmington	297
Dublin	250
Princeton	249
Cambridge	245
Izmir	204
Nyköping	193
Boardman	156
Dong Ket	143
Como	123
Rome	122
Singapore	118
Beijing	82
New York	78
San Diego	58
Ogden	52
Helsinki	50
San Mateo	46
Brussels	36
Kocaeli	32
Munich	30
Chicago	29
Hefei	28
Nanjing	26
Santa Clara	25
Kunming	23
Tokyo	23
Toronto	23
Verona	23
Washington	20
Jinan	19
Norwalk	18
Guangzhou	17
London	17
Los Angeles	16
Dallas	15
Düsseldorf	15
Berlin	12
Brno	12
Edinburgh	12
Falls Church	10
Kilburn	10
Magnago	10
Pune	10
Fuzhou	9
Nanchang	9
Phoenix	8
Aprilia	7
Hebei	7
Inverigo	7
Wilnsdorf	7
Philadelphia	6
Redmond	6
Redwood City	6
Shenyang	6
Wuhan	6
Gallarate	5
Giussano	5
Hangzhou	5
Olomouc	5
Perugia	5
Changsha	4
Chiswick	4
Frankfurt am Main	4
Naples	4
West Jordan	4
Zhengzhou	4
Chongqing	3
Falkenstein	3
High Point	3
Islington	3
Lausanne	3
Luxembourg	3
Madrid	3
Paris	3
Prescot	3
San Francisco	3
Shanghai	3
Vanzago	3
Varese	3
Wenzhou	3
Xian	3
Zurich	3
Amsterdam	2
Auburn Hills	2
Auckland	2
Baotou	2
Belgrade	2
Bergamo	2
Budapest	2
Busto Arsizio	2
Totale	9.547

Salva come PNG Salva come JPEG

Nome	#
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells	187
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1	179
Investigating Human T Cell Lymphotropic Retrovirus (HTLV) tax function with molecular and immunophenotypic techniques	176
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)	173
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state	170
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells	167
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	166
CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches	163
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	156
HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients	155
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1	148
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators	145
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	141
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation.	140
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication	137
The guanine nucleotide exchange factor Ras-GRF1 directly binds microtubules via DH-PH2 mediated interaction	137
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects	133
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1.	133
Tripartite motif 22 and class II transactivator restriction factors: Unveiling their concerted action against retroviruses	132
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	130
The guanine nucleotide exchange factor Ras-GRF1 directly binds microtubules via DH-PH2 mediated interaction	129
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	129
CIITA-driven MHC class II expressing tumor cells as antigen presenting cell performers: Toward the construction of an optimal anti-tumor vaccine	126
Three kinds of currents in the canine betaine-GABA transporter BGT-1 expressed in Xenopus laevis oocytes	125
Role of anion-cation interactions on the pre-steady-state currents of the rat Na(+)-Cl(-)-dependent GABA cotransporter rGAT1	125
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization	124
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma	124
New approaches of cancer vaccination and cancer immunotherapy based on the optimal stimulation of tumor-specific, MHC class II-restricted CD4+ T helper cells	123
Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines	123
Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication.	121
Nociceptor-specific gene deletion reveals a major role for Na(v)1.7 (PN1) in acute and inflammatory pain	120
The MHC-II transactivator CIITA inhibits Tat-mediated HIV-1 LTR transactivation and virus replication in human U937 monocytic cells	119
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes	119
Autoimmunità e Malattie Autoimmuni	118
Tumor Immunology meets Immunology: Modified cancer cells as professional APC for priming naÃ¯ve tumor-specific CD4+ T cells	118
Modulation of the inward rectifier potassium channel IRK1 by the Ras signaling pathway	118
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1	116
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-kappa B by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein	116
Temperature effects on the presteady-state and transport-associated currents of GABA cotransporter rGAT1	116
The guanine nucleotide exchange factor RasGRF1 directly binds microtubules via DHPH2-mediated interaction	115
The MHC class II transactivator CIITA inhibits the persistent activation of NF-kB by Human T cell Lymphotropic Virus type-1 Tax-1 oncoprotein	115
Tax-1-mediated HTLV-1 replication and NF-kB activation is inhibited by the MHC-II transactivator CIITA	114
The MHC Class II transactivator, CIITA,is a viral restriction factor for human oncogenic retroviruses	113
Probiotic Bifidobacterium lactis, anti-oxidant vitamin E/C and anti-inflammatory dha attenuate lung inflammation due to pm2.5 exposure in mice	113
DNA ricombinante	112
Modulation of extracellular signal-regulated kinases cascade by cronic Delta(99-tetrahydrocannabinol treatment	112
The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis	112
The guanine nucleotide exchange factor Ras-GRF1 directly binds microtubules via DH-PH2 mediated interaction	110
HTLV-1 HBZ viral protein: A key player in HTLV-1 mediated diseases	110
Tax-1-mediated NF-kB activation is inhibited by the MHC-II transactivator CIITA	109
Na+ AND Cl- INTERACTIONS AT THE NEURONAL GABA COTRANSPORTER rGAT1	108
Biophysics and molecular physiology of membrane transport systems	108
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication	108
Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment	105
pH sensitivity conferred to rGAT1 gaba transporter by mutations in the extracellular loop 5.	104
Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization	104
Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation	103
The constitutive activation of NF-kB by HTLV-1 Tax-1 oncoprotein is inhibited by the MHC class II transactivator CIITA	103
Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1	103
Na+ AND Cl- EFFECTS ON THE NEURONAL GABA COTRANSPORTER rGAT1	101
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	101
Nociceptor-specific gene deletion using heterozygous Na(v)1.8-Cre recombinase mice	99
-K448E mutation in the extracellular loop 5 rGAT1 gaba transporter induces alterations in interactions of substrates	98
CIITA dependent MHC class II IA expression in tumor cells triggers CD4 T cell protective and long lasting antitumor immunity	98
Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model.	97
Host-retrovirus interaction: role of CIITA in the inhibition of HTLV-1 replication and oncogenic potential	97
K448E mutation in the extracellular loop 5 of rgat1 gaba transporter induces alterations in interactions of substrates	97
Modulation of the inward rectifier potassium channel IRK1 by the Ras pathway	96
Identification and characterization of proteins that, interacting with MeCP2, could be involved in Rett Syndrome	95
Mutations in specific aminoacid residues confer ph sensitivity to the rat gaba cotrasporter Gat1	93
Functional Characterization of CDKL5, a Novel Gene Involved in The Onset of Rett Syndrome and Infantile Spasms.	93
CIITA-transfected tumor cells as potent, widely applicable anti-tumor vaccine due to their optimal triggering of long-lasting tumor-specific CD4+ T helper cells	93
Electrophysiological properties of the canine betaine/GABA transporter BGT-1 expressed in Xenopus laevis oocytes.	93
Association of the neuron specific Ras-exchange factor Ras-GRF1 with the microtubules cytoskeleton	93
An episode of oral mucositis after the first administration of the ChAdOx1 COVID-19 vaccine	93
Modulation of the inward rectifier potassium channel IRK1 by the Ras pathway	91
Electrophysiological properties of the canine betaine/GABA transporter BGT-1 expressed in Xenopus laevis oocytes.	90
Modulation of the inward rectifier potassium channel IRK1 by the Ras signalling pathway	89
Modulation of the inward rectifier potassium channel IRK1 by the Ras pathway	89
Altered sodium binding induced by K448E mutation in the extracellular loop 5 of GAT1 GABA transporter	89
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients	88
Distinct subcellular localization of HTLV-1 HBZ oncoprotein in the ATL leukemic and HAM/TSP patients.	87
Molecular characterization of the CDKL5 gene involved in mental retardation and infantile spams	86
Ras-GRF1, a neuron specific guanine nucleotide exchange factor acting both on Ras and Rac, interacts with microtubules	85
Stability and localization of RAs-GRF1	84
Functional Characterization of CDKL5, a novel gene involved in the onset of Rett syndrome	84
Mutation K448E in the external loop 5 of rat GABA transporter rGAT1 induces pH sensitivity and alters substrates interactions	83
Modulation of the inward rectifier potassium channel IRK1 by the Ras signalling pathway	82
Functional characterization of CDKL5, a novel gene involved in Rett syndrome and infantile spams associated with mental retardation	81
MHC-II transactivator CIITA, a novel viral restriction factor against HIV-1 infection	81
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication	80
The modulation of the inward rectifier potassium channel IRK1 by the Ras pathway	80
Mutation in Specific amino acid residues confer pH sensitivity to the rat GABA cotransporter GAT1	80
Functional characterization of CDKL5, a novel gene involved in Rett Syndrome and infantile spams	79
Na+ and Cl- interactions at the neuronal GABA cotransporter rGAT1	79
Modulation of the inward rectifier potassium channel IRK1 by the ras signalling pathway	79
Na+/Cl-effects on the neuronal GABA cotransporter rGAT1	78
Modulation of extracellular signal-regulated kinases cascade by chronic Delta(9)-tetrahydrocannabinol treatment	77
Modulation of the inward rectifier potassium channel IRK1 by the Ras cascade	77
Functional characterization of CDKL5, a novel gene involved in the onset of Rett Syndrome	77
Totale	11.170

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	48.434
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	48.434

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	1.761	0	0	0	0	152	363	430	288	145	181	36	166
2020/2021	1.869	37	167	103	163	73	167	70	215	282	132	174	286
2021/2022	1.166	161	123	57	94	53	50	37	61	64	178	130	158
2022/2023	1.667	158	36	74	177	137	388	1	225	247	91	80	53
2023/2024	3.127	500	488	523	563	557	268	14	37	87	21	13	56
2024/2025	535	20	18	343	104	50	0	0	0	0	0	0	0
Totale													13.026